Baxter International (BAX) EPS (Weighted Average and Diluted) (2009 - 2026)
Baxter International (BAX) reported EPS (Weighted Average and Diluted) of -$0.03 for Q1 2026, down 112.0% year-over-year from $0.25 in Q1 2025, and up 83.45% quarter-over-quarter from -$0.18 in Q4 2025.
Baxter International (BAX) EPS (Weighted Average and Diluted) (2009 - 2026) Analysis & Trends
Baxter International (BAX) has 18 years of EPS (Weighted Average and Diluted) data on file, last reported at -$0.03 in Q1 2026.
- EPS (Weighted Average and Diluted) for Q1 2026 came in at -$0.03, down 112.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$0.51 (up 53.64% YoY), and the FY2025 annual result was -$1.87, down 192.19% from the prior year.
- EPS (Weighted Average and Diluted) climbed to -$0.03 in Q1 2026 per BAX's latest filing, from -$0.18 in the prior quarter.
- Over five years, EPS (Weighted Average and Diluted) peaked at $0.43 in Q4 2023 and troughed at -$5.94 in Q3 2022.
- A 5-year average of -$0.39 and a median of $0.07 in 2023 frame the typical range for EPS (Weighted Average and Diluted).
- The sharpest annual moves came in 2022 and 2024: EPS (Weighted Average and Diluted) surged 660.0% in 2022, then sank 1140.0% in 2024.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $0.28 in 2022, then jumped by 53.57% to $0.43 in 2023, then tumbled by 332.56% to -$1.0 in 2024, then jumped by 81.87% to -$0.18 in 2025, then soared by 83.45% to -$0.03 in 2026.
- Business Quant data shows BAX's EPS (Weighted Average and Diluted) at -$0.03 in Q1 2026, -$0.18 in Q4 2025, and $0.25 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 2.28 |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -1.11 |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 0.16 |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 2.74 |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 1.92 |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 0.07 |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -0.40 |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 1.57 |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -0.03 |
| 10 | Aptargroup | 7.72 Bn | 7.52 Bn | 351.91 Mn | 1.12 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.03 |
| Dec 31, 2025 | -0.18 |
| Mar 31, 2025 | 0.25 |
| Dec 31, 2024 | -1.00 |
| Sep 30, 2024 | 0.27 |
| Jun 30, 2024 | -0.62 |
| Mar 31, 2024 | 0.07 |
| Dec 31, 2023 | 0.43 |
| Sep 30, 2023 | 0.07 |
| Jun 30, 2023 | -0.05 |
| Mar 31, 2023 | 0.09 |
| Dec 31, 2022 | 0.28 |
| Sep 30, 2022 | -5.94 |
| Jun 30, 2022 | 0.36 |
| Mar 31, 2022 | 0.14 |
| Dec 31, 2021 | -0.05 |
| Sep 30, 2021 | 0.89 |
| Jun 30, 2021 | 0.59 |
| Mar 31, 2021 | 0.58 |
| Dec 31, 2020 | 0.33 |